Case Stories
The importance of molecular testing to improve cancer patient outcomes - Dr. Allan Njau
338 views
Dr. Allan Njau, Anatomical Pathologist at the Aga Khan University Hospital, Kenya, discusses the importance of molecular testing to improve cancer patient outcomes.
Cancer incidence rates in Kenya are high and accompanied by elevated morbidity and mortality. Dr. Allan Njao discusses how molecular NGS testing paired with a comprehensive bioinformatics analysis and reporting pipeline, can help improve cancer patient outcomes.
Interested in learning more?
Click here
Related videos
Case Stories
The importance of a good bioinformatics pipeline for determining TMB score
Tumor mutational burden is an important biomarker for immuno-oncology. Dr...
Case Stories
Dr. Sehime Temel of the Department of Medical Genetics at Uludag University discusses QDI
Trying to find the appropriate genetic variant without bioinformatics is as...
Case Stories
Dr. Kambiz Karimi about the comprehensiveness of QIAGEN clinical insights
Dr. Kambiz Karimi, Curation Manager at Counsyl, presented data as ASHG which...
Case Stories
#AACR19 Interview with Deep Pandya
Deep Pandya, Bioinformatician at the Western Connecticut Health Network,...